Figure 1
Figure 1. Fibrinolytic parameters in cases and controls. Comparison of plasma levels of t-PA antigen (A), PAI-1 activity (B), TAFI activity (C), plasmin inhibitor activity (D), fibrinogen (E), and FXIII (F) between patients with BCS (cases, n = 101) and healthy controls (n = 101). For t-PA antigen and PAI-1, the log-transformed values are depicted. (G) CLTs (in minutes) of patients with BCS (cases, n = 100) and healthy controls (n = 101) as measured using a plasma-based in vitro clot lysis assay. Individual data points and median values are given.

Fibrinolytic parameters in cases and controls. Comparison of plasma levels of t-PA antigen (A), PAI-1 activity (B), TAFI activity (C), plasmin inhibitor activity (D), fibrinogen (E), and FXIII (F) between patients with BCS (cases, n = 101) and healthy controls (n = 101). For t-PA antigen and PAI-1, the log-transformed values are depicted. (G) CLTs (in minutes) of patients with BCS (cases, n = 100) and healthy controls (n = 101) as measured using a plasma-based in vitro clot lysis assay. Individual data points and median values are given.

Close Modal

or Create an Account

Close Modal
Close Modal